Bachelor's Degree with 5+ years in biopharmaceutical sales; specialty therapeutic experience preferred.
Experience in selling and demonstrating reconstitution and injection processes is essential.
Proven track record of success in sales and strategic account management.
Strong understanding of the patient and provider landscape in cardiology.
Knowledge of compliant and ethical business practices is required.
Ability to collaborate effectively with internal and external stakeholders.
Demonstrated drive, passion, and focus for contributing to a global generational company.
Experience in developing and executing territory strategies for new drug launches is a plus.
Willingness to travel up to 75% of the time within the assigned territory.
Responsibilities
Develop and execute a strategic territory plan aligned with commercial objectives.
Achieve commercial goals set for the product launch.
Educate healthcare providers on the features and benefits of rilonacept.
Serve as the primary representative for key healthcare stakeholders.
Drive efficiencies with medical and payer field teams.
Identify and build advocacy with influential thought leaders in recurrent pericarditis.
Maintain updated customer profiles and institutional formularies.
Facilitate collaborative opportunities through various engagement methods.
Continuously enhance technical and clinical expertise in the therapeutic area.
Promote a positive brand image as Kiniksa enters the marketplace.
Benefits
Comprehensive overview of Kiniksa's Patient Services and support program.
Opportunities for professional development and attending scientific meetings.
Collaborative work environment with cross-functional teams.
Potential for significant contributions to a growing global company.
Full Job Description
Reporting to the Regional Sales Director, the Clinical Sales Specialist (CSS) has the opportunity to contribute to the unique and exciting launch of rilonacept in recurrent pericarditis by educating healthcare providers and staff on recurrent pericarditis, drug efficacy and safety, treatment and administration, and patient services. The CSS is responsible for customer account targeting and planning across the assigned territory to maximize the customer and patient experience and deliver on business opportunities for Kiniksa.
Responsibilities (including, but not limited to):
Develop and execute a strategic territory plan aligned with Kiniksa's commercial objectives including prioritized territory and account management, business planning and analysis, and resource allocation
Achieve the commercial goals set for launch
Always act in a compliant manor with integrity aligned with Kiniksa's values
Educate targeted institutional decision makers, cardiologists and rheumatologists on the features, advantages and benefits of rilonacept
Serve as the primary Kiniksa external representative for key HCP stakeholders , establishing oneself as a reliable, trusted resource for company and product information, appropriate use and dosing
Drive cross-functional efficiencies and synergy with Kiniksa's medical and payer field teams
Identify and build advocacy with influential and respected recurrent pericarditis Thought Leaders
Maintain updated customer and account profiles including institutional formularies and pathways and payer policies
Provide a comprehensive overview on Kiniksa's best-in class Patient Services and support program
Facilitate collaborative opportunities aligned with Kiniksa's mission, strategy and objectives through multiple venues, (virtual and in-person where applicable) one-on-one interactions, small group discussions, peer-to-peer programs and presentations with external key stakeholders
Continuously build and maintain technical and clinical expertise across therapeutic areas and customer needs & expectations (territory market landscape, competitors, market segments/dynamics, disease state) to enable deep scientific discourse externally
Maintain up-to-date knowledge on customer and healthcare trends within the cardiology space
Promote a positive organization and brand image as Kiniksa enters the marketplace
Attend appropriate scientific meetings
Leverage clinical expertise to educate nurses on the administration of rilonacept
Comply with applicable laws, internal and external guidelines, policies and procedures that govern Kiniksa activities
Maintain expenses within assigned budget parameters
Document field activities accurately and in a timely fashion
Qualifications and Experience:
Requires a Bachelor's Degree with 5+ years of biopharmaceutical sales experience; specialty therapeutic experience. Cardiology experience is a plus
Experience selling and demonstrating reconstitution and injection process is a must
Candidates must demonstrate a track record of success
Strong knowledge of the evolving patient and provider landscape
Demonstrated working knowledge of compliant and ethical business practices
Must exhibit a strong background in collaborating with internal and external stakeholders
Must exhibit characteristics that exemplify drive, passion and focus that will translate into significant contributions towards building a global generational company focused on Kiniksa's patients and customers
Must demonstrate the ability to effectively & efficiently manage multiple workstreams
Experience developing and executing a territory strategy with new drug launches preferred
Must be willing to travel up to 75% of the time (primarily in the assigned territory) and hold a valid driver's license
Compensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks. In addition to base pay, this role includes a Sales Incentive plan.
Sales pay range
$195,000-$205,000 USD
About Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients suffering from debilitating diseases with significant unmet medical need. The company's pipeline includes several product candidates targeting autoinflammatory and autoimmune diseases. Kiniksa Pharmaceuticals was founded in 2015 and is headquartered in Lexington, Massachusetts. The company is committed to advancing science and improving the lives of patients through innovative research and development.
